banner-image
Dr-Fitzgerald-1

Rebecca Fitzgerald, MD, FAAD

Advocating the proverbial “ounce of prevention” approach, Dr. Fitzgerald favors correcting “a little bit all along” rather than waiting for substantial changes that make correction more costly.

Dr. Rebecca Fitzgerald is a Diplomate of the American Board of Dermatology and a Fellow of both the American Academy of Dermatology (AAD) and the American Society of Dermatological Surgery (ASDS).

A New Orleans native, Dr. Fitzgerald graduated from Louisiana State University (LSU) Medical School. She subsequently completed an Internal Medicine residency at UCLA/Cedars Sinai Medical Center (CSMC) in Los Angeles, California before returning home to New Orleans, where she completed her training in Dermatology. She returned to California following her post-graduate training and is pleased to continue serving the greater Los Angeles area from her Larchmont location.

The Exceptional Women award: This distinction recognizes female Castle Connolly Top Doctors who have demonstrated outstanding leadership, expertise, and dedication in their respective fields. In addition to meeting the requirements to be selected as a Castle Connolly Top Doctor, these doctors also have additional qualifications, including research and academic contributions, volunteer work within healthcare, and training at top institutions.

Selected as a Top Doctor by Castle Connolly every year since 2014, Dr. Rebecca Fitzgerald has gained the highest respect from her peers. She has also been awarded the Exceptional Women in Medicine distinction every year since 2016.

Since 2016, she has been selected by Super Doctors as one of the outstanding doctors from more than 40 medical specialties who have attained a high degree of peer recognition or professional achievement.

Dr. Fitzgerald has published in peer-reviewed medical journals, presented at medical educational seminars, and has been featured as a medical expert on local and national television programs. She is very active academically and is heavily involved in research and training and is sought after internationally for her physician training abilities and as a specialty speaker for professional gatherings around the globe.

Visit our Media Page to see Dr. Rebecca Fitzgerald’s coverage

CONTACT US TODAY

Selected as a Top Doctor by Castle Connolly every year since 2014, Dr. Rebecca Fitzgerald has gained the highest respect from her peers. She has also been awarded the Exceptional Women in Medicine distinction every year since 2016.

Since 2016, Dr. Fitzgerald has been selected by Super Doctors as one of the outstanding doctors from more than 40 medical specialties who have attained a high degree of peer recognition or professional achievement.

 

Dr. Fitzgerald has published in peer-reviewed medical journals, presented at medical educational seminars, and has been featured as a medical expert on local and national television programs. She is very active academically and is heavily involved in research and training and is sought after internationally for her physician training abilities and as a specialty speaker for professional gatherings around the globe.

Curriculum Vitae (PDF) – Training, Academic Accomplishments, Publications, Media  and Presentations

Visit our Media Page to see Dr. Rebecca Fitzgerald’s coverage

Education & Training

Resident in Dermatology

Louisiana State University Medical Center  ·  New Orleans, Louisiana

1992 – 1995
Resident in Internal Medicine

UCLA / Cedars Sinai Medical Center  ·  Los Angeles, California

1989 – 1990
Doctor of Medicine (MD)

Louisiana State University School of Medicine  ·  New Orleans, Louisiana

1985 – 1989

Board Certification & Licensure

Board Certification & Licensure

Certified 1995  ·  Recertified 2013

1995 – Present
Medical Board of California

Active License

1990 – Present
Louisiana State Board of Medical Examiners

Active License

2010 – Present

Professional Experience

Private Practice

Rebecca Fitzgerald MD Dermatology  ·  Los Angeles, California

2005 – Present
Clinical Instructor of Medicine

UCLA Department of Medicine  ·  Los Angeles, California

2006 – 2017
Dermatologist

Southern California Kaiser Permanente  ·  Panorama City, California

1998 – 2007
Dermatologist

Northeast Dermatology Associates  ·  Boston, Massachusetts

1997 – 1998
Acting Chief of Dermatology

Stanocola Medical Center  ·  Baton Rouge, Louisiana

1995 – 1997

Publications

Deliberations of the Safety Task Force: Risk factors and treatment of adverse events associated with aesthetic injectables.

Nikolis A, Cohen JL, Enright KM, Avelar L, Beleznay K, Biesman B, Cartier H, Cotofana S, Fabi S, Fitzgerald R, et al. — Cosmet Dermatol. 2024 Aug 20. PMID: 39161297

Update on Blindness from Filler: Review of Prognostic Factors, Management Approaches, and a Century of Published Cases.

Doyon VC, Liu C, Fitzgerald R, Humphrey S, Jones D, Carruthers JDA, Beleznay K. — Aesthet Surg J. 2024 Apr 17. PMID: 38630871

Migration of Hyaluronic Acid-Based Soft Tissue Filler From the Temples to the Cheeks — An Anatomic Explanation.

Almukhtar R, Fitzgerald R, Cotofana S, Fabi S. — Dermatol Surg. 2021 Nov 1;47(11):1526–1527. PMID: 34417376

Development of Objective Structured Assessment of Technical Skills in Facial Cosmetic Procedures: Botulinum Toxin Neuromodulator and Soft Tissue Filler Injection.

Suozzi KC, Kibbi N, Lee KC, Worley B, … Fitzgerald R, et al. — J Am Acad Dermatol. 2021 Sep. PMID: 34499988

Descriptive Analysis of 213 Positive Blood Aspiration Cases When Injecting Facial Soft Tissue Fillers.

Tseng FW, Bommareddy K, Frank K, DeLorenzi C, Green JB, Sadick N, Fitzgerald R, et al. — Aesthet Surg J. April 2021: sjaa075

Preventing and Treating Adverse Events of Injectable Fillers: Evidence-Based Recommendations From the ASDS Multidisciplinary Task Force.

Jones DH, Fitzgerald R, Cox SE, Butterwick K, Murad MH, et al. — Dermatol Surg. Feb 2021;47(2):214–226.

Subunit Approach to Facelifting and Facial Rejuvenation.

Azizzadeh B, Fitzgerald R, Massry G, Smith E. — Facial Plast Surg Clin North Am. Aug 2020;28(3):253–272.

Nonsurgical Modalities to Treat the Aging Face.

Fitzgerald R, Graivier MH, Kane M, Lorenc ZP, Vleggaar D, Werschler WP, Kenkel JM. — Aesthet Surg J. Jul-Aug 2020;30:S31–5 (Supplement).

An Approach to Structural Facial Rejuvenation with Fillers in Women.

Fitzgerald R, Carqueville J, Yang PT. — Int J Women’s Dermatol. Dec 2018;5(1):57–67.

Injectable Fillers: Panel Discussion, Controversies, and Techniques.

Kontis T, Bunin L, Fitzgerald R. — Facial Plast Surg Clin North Am. May 2018;26(2):225–236.

Expanding Treatment Options for Injectable Agents.

Goldberg DJ, Bass LM, Fitzgerald R, Graivier MH, Lorenc ZP. — Aesthet Surg J. May 2018;38:S1–S7 (Supplement).

Physiochemical Characteristics of Calcium Hydroxylapatite (CaHA).

Lorenc ZP, Bass LM, Fitzgerald R, Goldberg DJ, Graivier MH. — Aesthet Surg J. May 2018;38:S8–S12 (Supplement).

Physiochemical Characteristics of Poly-L-Lactic Acid (PLLA).

Fitzgerald R, Bass LM, Goldberg DJ, Graivier MH, Lorenc ZP. — Aesthet Surg J. May 2018;38:S13–17 (Supplement).

Composite Facial Volumization With Calcium Hydroxylapatite (CaHA) for the Treatment of Aging.

Lorenc ZP, Bass LM, Fitzgerald R, Goldberg DJ, Graivier MH. — Aesthet Surg J. May 2018;38:S18–23 (Supplement).

Calcium Hydroxyapatite (CaHA) Indication for Hand Rejuvenation.

Graivier MH, Lorenc ZP, Bass LM, Fitzgerald R, Goldberg DJ. — Aesthet Surg J. May 2018;38:S24–28 (Supplement).

Differentiating Nonpermanent Injectable Fillers: Prevention and Treatment of Filler Complications.

Graivier MH, Bass LM, Lorenc ZP, Fitzgerald R, Goldberg DJ, Lemperle G. — Aesthet Surg J. May 2018;38:S29–40 (Supplement).

Facial Soft Tissue Augmentation in Males: An Anatomical and Practical Approach.

Rossi AM, Fitzgerald R, Humphrey S. — Dermatol Surg. Nov 2017;43:S131–S139 (Supplement).

Addressing Facial Shape and Proportions with Injectable Agents in Youth and Age. [Book Chapter]

Fitzgerald R. In Azizzadeh B, Murphy M, Johnson C. “Master Techniques in Facial Rejuvenation.” Elsevier, June 2017.

Adverse Reactions to Injectable Fillers.

Fitzgerald R, Bertucci V, Sykes JM, Duplechain JK. — Facial Plast Surg. Oct 2016;32(5).

Choosing the Best Procedure to Augment the Chin: Is Anything Better than an Implant?

Sykes JM, Fitzgerald R. — Facial Plast Surg. Oct 2016;32(5).

Combination Therapy in Midfacial Rejuvenation.

Humphrey S, Beleznay K, Fitzgerald R. — Dermatol Surg. May 2016;42(2) Supplement.

Collagen Stimulators: Poly-L-Lactic Acid and Calcium Hydroxyl Apatite.

Breithaupt A, Fitzgerald R. — Facial Plast Surg Clin North Am. Nov 2015;23(4):225–236.

Introduction to "Soft-Tissue Fillers and Neuromodulators: International and Multidisciplinary Perspectives."

Fagien S, Fitzgerald R, Matarasso A. — Plast Reconstr Surg. Nov 2015;136(5) Supplement.

Midface: Clinical Anatomy and Regional Approaches with Injectable Fillers.

Cotofana S, Schenck TL, Trevidic P, Sykes J, Massry GG, … Fitzgerald R, et al. — Plast Reconstr Surg. Nov 2015;136(5) Supplement.

Current Concepts in the Use of PLLA: Clinical Synergy with Combined Use of Microfocused Ultrasound on the Face, Neck and Décolletage.

Hart DR, Fabi SG, White WM, Fitzgerald R, Goldman MP. — Plast Reconstr Surg. Nov 2015;136(5) Supplement.

Volume Rejuvenation of the Lower Third, Perioral, and Jawline; Middle Third; Upper Third. [3 articles]

Buckingham ED, Glasgold R, Kontis T, Smith SP Jr, Dolev Y, Fitzgerald R, et al. — Facial Plast Surg. Feb 2015;31(1).

Contemporary Concepts in Brow and Eyelid Aging. [Book Chapter]

Fitzgerald R. In Azizzadeh B, Massry G. “Brow and Upper Eyelid Surgery: Multispecialty Approach.” Elsevier, Jan 2013.

Filler Placement and the Fat Compartments.

Rubin A, Fitzgerald R. — Dermatol Clin. Jan 2014;32(1):37–50.

Composition and Mechanism of Action of Poly-L-Lactic Acid in Soft Tissue Augmentation.

Vleggaar D, Fitzgerald R, Lorenc ZP. — J Drugs Dermatol. Apr 2014;13(4) Supplement.

The History Behind the Use of Injectable Poly-L-Lactic Acid for Facial and Nonfacial Volumization.

Vleggaar D, Fitzgerald R, Lorenc ZP. — J Drugs Dermatol. Apr 2014;13(4) Supplement.

Understanding, Avoiding, and Treating Potential Adverse Events Following Injectable Poly-L-Lactic Acid.

Vleggaar D, Fitzgerald R, Lorenc ZP. — J Drugs Dermatol. Apr 2014;13(4) Supplement.

Satisfying Patient Expectations With Poly-L-Lactic Acid Soft Tissue Augmentation.

Vleggaar D, Fitzgerald R, Lorenc ZP. — J Drugs Dermatol. Apr 2014;13(4) Supplement.

Consensus Recommendations on the Use of Injectable Poly-L-Lactic Acid for Facial and Nonfacial Volumization.

Vleggaar D, Fitzgerald R, Lorenc ZP, et al. — J Drugs Dermatol. Apr 2014;13(4) Supplement.

Fillers and the "Three Curves of Youth."

Fitzgerald R. — J Drugs Dermatol. Aug 2012;11(8):S9–11.

Poly-L-Lactic Acid. [Book Chapters, 2012 & 2017 editions]

Fitzgerald R. In Carruthers J, Carruthers A. “Soft Tissue Augmentation: Procedures in Cosmetic Dermatology Series.” Elsevier.

Facial Soft-Tissue Fillers Conference: Assessing the State of the Science.

Hanke CW, Rorrich RJ, Busso M, Carruthers A, Carruthers J, Fagien S, Fitzgerald R, et al. — Plast Reconstr Surg. Apr 2011;127(4). & J Am Acad Dermatol. 2011;64(4):S66–85.

Facial Volume Restoration of the Aging Face with Poly-L-Lactic Acid.

Fitzgerald R, Vleggaar D. — Dermatol Ther. Jan-Feb 2011;24(1):2–27.

Appropriate Selection and Application of Nonsurgical Facial Rejuvenation Agents and Procedures: Panel Consensus Recommendations.

Fitzgerald R, Graivier MH, Kane M, Lorenc ZP, Vleggaar D, Werschler WP, Kenkel JM. — Aesthet Surg J. Jul-Aug 2010;30:S36–45.

Facial Shaping: Beyond Lines and Folds with Fillers.

Patel U, Fitzgerald R. — J Drugs Dermatol. Aug 2010;9(8):S129–137.

Update on Facial Aging / Facial Aesthetic Analysis / Surgical vs Nonsurgical Rejuvenation. [Supplement series]

Fitzgerald R, Graivier MH, Kane M, Lorenc ZP, Vleggaar D, Werschler WP, Kenkel JM. — Aesthet Surg J. Jul-Aug 2010;30 (Supplement).

Using Poly-L-Lactic Acid (PLLA) to Mimic Volume in Multiple Tissue Layers.

Fitzgerald R, Vleggaar D. — J Drugs Dermatol. Oct 2009;8(10):S5–14.

Advanced Techniques for Sculptra.

Fitzgerald R. — J Drugs Dermatol. Apr 2009;8(4 Suppl):s17–21.

Facial Dermal Fillers.

Fitzgerald R, Vleggaar D, Burgess C. — Aesthet Surg J. Nov-Dec 2008;28(6):699–701.

Poly-L-Lactic Acid Injection for HIV-Associated Facial Lipoatrophy: Treatment Principles, Case Studies, and Literature Review.

Kates L, Fitzgerald R. — Aesthet Surg J. Jul-Aug 2008;28(4):397–403.

Dermatologic Implications of Skeletal Aging: A Focus on Aesthetic Correction of the Lower Face.

Vleggaar D, Fitzgerald R. — J Drugs Dermatol. Mar 2008;7(3):209–20.

Late Appearing Abscesses After BioAlcamid Injections for HIV-Associated Facial Lipoatrophy.

Jones DH, Carruthers A, Fitzgerald R, Sarantopoulos GP, Binder S. — J Dermatol Surg. Dec 2007;33(2):S193–S198.

Treatment Options for Facial Lipoatrophy.

Fitzgerald R. — Cosmetic Dermatology. 2006;19(4 Suppl 2):12–20.

CTCL in Patients Under Twenty Years of Age: A Series of Five Reports.

Hickman PR, McBurney EI, Fitzgerald RL. — J Ped Dermatol. 1997;14:93–97.

Sweet's Syndrome.

Fitzgerald RL, McBurney EI, Nesbit LT. — Int J Dermatol. 1996;35:9–15.

Expert Injector and Physician Trainer

Rebecca Fitzgerald MD is a BOTOX Cosmetic National Education Facility and Black Diamond (top 1%) provider for Allergan injectables. As an International Master training physician for Sculptra, Dr. Fitzgerald travels around the country and the world teaching other physicians the advanced injection techniques required for the use of Sculptra.

Book_Logos
Call to Schedule A Consultation

Send us a message or give us a call at (323) 464-8046

 


    [mc4wp_checkbox]

    Rebecca Fitzgerald, MD, FAAD Rebecca Fitzgerald, MD, FAAD N/A

    Rebecca Fitzgerald

    Advocating the proverbial “ounce of prevention” approach, Dr. Fitzgerald favors correcting “a little bit all along” rather than waiting for substantial changes that make correction more costly.

    Dr. Rebecca Fitzgerald is a Diplomate of the American Board of Dermatology and a Fellow of both the American Academy of Dermatology (AAD) and the American Society of Dermatological Surgery (ASDS).

    A New Orleans native, Dr. Fitzgerald graduated from Louisiana State University (LSU) Medical School. She subsequently completed an Internal Medicine residency at UCLA/Cedars Sinai Medical Center (CSMC) in Los Angeles, California before returning home to New Orleans, where she completed her training in Dermatology. She returned to California following her post-graduate training and is pleased to continue serving the greater Los Angeles area from her Larchmont location.

    http://schema.org/Dermatology